8/20/08
3:40 PM
Save

Some experts think that the overly aggressive marketing of HPV vaccine Gardasil and the lobbying of Gardasil manufacturer Merck has led to the vaccine's potential over-prescription. According to the New York Times, "Some experts worry about the consequences of the rapid rollout of the new vaccines without more medical

6/25/08
3:40 PM
Save

Gardasil has been denied delayed approval by the FDA for use in women ages 27-45. According to Reuters, "The U.S. Food and Drug Administration said in a letter regarding the application that it has completed its review and there are 'issues' that preclude approval within the expected review time frame." Merck was also

3/20/08
12:45 PM
Save

According to news reports, the FDA will decide whether or not to extend the the administration of Gardasil, the HPV vaccine, to women ages 27-45, by this summer. Currently, Gardasil is only approved for use in women ages 9-26. A spokeswoman for Merck, the company that produces Gardasil, emphasized that the vaccine

Advertisement